
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 10.390 | 10.750 | 0.360 |
Shares | 89.620 | 89.620 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.515 | 19.611 |
Price to Book | 1.242 | 3.844 |
Price to Sales | 0.714 | 2.221 |
Price to Cash Flow | 7.800 | 14.840 |
Dividend Yield | 1.738 | 1.499 |
5 Years Earnings Growth | 7.488 | 10.202 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 79.500 | 94.361 |
Financial Services | 8.120 | 7.763 |
Industrials | 4.750 | 3.090 |
Consumer Cyclical | 3.940 | 7.067 |
Consumer Defensive | 3.690 | 3.332 |
Number of long holdings: 37
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Georgia Capital | GB00BF4HYV08 | 7.28 | 2,095.00 | +0.24% | |
Fresenius SE | DE0005785604 | 5.96 | 41.180 | +0.59% | |
3SBio | KYG8875G1029 | 5.32 | 30.60 | +9.48% | |
Fagron | BE0003874915 | 4.85 | 21.60 | -0.46% | |
Eurofins Scientific | FR0014000MR3 | 4.58 | 60.62 | +0.26% | |
Krka | SI0031102120 | 4.46 | 199.00 | 0.00% | |
Medios AG | DE000A1MMCC8 | 4.37 | 12.6000 | +0.16% | |
AGFA Gevaert | BE0003755692 | 4.26 | 1.02 | +1.59% | |
Uniphar | IE00BJ5FQX74 | 4.14 | 3.56 | +2.45% | |
Dermapharm | DE000A2GS5D8 | 3.89 | 34.85 | +0.87% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ACATIS Fair Value Modulor Vermogeni | 284.93M | -1.84 | -0.05 | 3.84 | ||
ACATIS Fair Value Modulor Vermogens | 284.93M | -1.51 | 0.62 | 4.43 | ||
FU Fonds Multi Asset Fonds P | 105.23M | -3.53 | 6.27 | 6.74 | ||
HA Aktien Small Cap EMU B | 87.52M | 14.08 | 9.58 | 7.23 | ||
H A Aktien Small Cap EMU A | 87.52M | 14.07 | 9.57 | 7.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review